NEWS COMMENTARY

Ÿnsect snags $375 million Series C, escalating the buzz around insect protein

Published:
October 08, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Investment More...
Very important

Mealworm producer Ÿnsect has raised an additional $224 million for its $148 million Series C, bringing the round to $372 million in total. Investors of the latest funding include Upfront Ventures and celebrity Robert Downey Jr.'s FootPrint Coalition. From its first Series C announcement, Ÿnsect planned for a commercial-scale facility that would produce 20,000 MT of protein per year. The facility is now anticipated to produce 100,000 MT per year as early as 2022. Clients, few insect protein companies have claimed expectations of reaching a production scale that comes close to this, and those that have displayed significantly less funding; if Ÿnsect pulls this facility off, it will be a precedent for the funding required to reach this scale.

For the original news article, click here .


Further Reading

Zeopore closes funding round led by Capricorn Partners

News Commentary | September 01, 2020

Capricorn Partners is a new investor for Zeopore and its first venture capital fund, alongside existing shareholders like The Innovation Fund and Gemma Frisius Fund. This announcement is aligned with Zeopore's intent from 2018 to seek VC funding. While the amount is undisclosed, Capricorn will need ... Not part of subscription

Mosa Meat raises $55 million Series B to commercialize cell-based meat

News Commentary | September 28, 2020

This investment round was led by Blue Horizon Ventures, with participation from previous strategic investors including Bell Food Group and M Ventures. Mosa Meat looks to move to a pilot production scale of 200 L capacity, operational by 2021. To this end, the company claims that it has successfully ... Not part of subscription

Unibio raises a $15 million bridge financing round and secures relationship with Stafilies

News Commentary | June 30, 2021

The $15 million came from existing investors, including West Hill Capital, and brings Unibio's valuation to more than $300 million. Unibio will use the funds to support business growth. The announcement coincides with the closing of Unibio's latest agreement with Stafilies – the parent company of ... Not part of subscription